Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction
Open Access
- 28 June 2003
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (1) , 1-6
- https://doi.org/10.1016/s0735-1097(03)00566-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial InfarctionJAMA, 2002
- Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarctionJournal of the American College of Cardiology, 2002
- Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarctionThe Lancet, 2001
- Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trialThe Lancet, 2001
- Trial of Abciximab With and Without Low-Dose Reteplase for Acute Myocardial InfarctionCirculation, 2000
- Abciximab Facilitates the Rate and Extent of ThrombolysisCirculation, 1999
- Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty: Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot studyJournal of the American College of Cardiology, 1999
- Restoration of Coronary Flow in Myocardial Infarction by Intravenous Chimeric 7E3 Antibody Without Exogenous Plasminogen ActivatorsCirculation, 1997
- Combined Accelerated Tissue-Plasminogen Activator and Platelet Glycoprotein IIb/IIIa Integrin Receptor Blockade With Integrilin in Acute Myocardial InfarctionCirculation, 1997
- Molecular and Cellular Biology of Blood CoagulationNew England Journal of Medicine, 1992